Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Some participants experienced noticeable appetite changes early in treatment, while meaningful weight reduction generally developed gradually over several months
It also helps us offer transparent pricing that is often more affordable than expected
With Blackstone Life Sciences, up to 300 million (around $315 million USD) will be invested to accelerate pivotal studies and clinical development programs for formulating the subcutaneous delivery of the anti-CD38 antibody Sarclisa (isatuximab) for the treatment of multiple myeloma
Results for this trial are not available [11]
Medical suitability is not however substituted with affordability
L.StevensA
US$ 26.41
US$ 24.38
US$ 25.05
US$ 26.24
US$ 27.84
